CardioBites

Thank you for viewing CardioBites.

Please complete this brief survey to assist in improving the program.

HFSA Staff

Amyloidosis - How is Amyloidosis diagnosed?

Amyloidosis - Multidisciplinary Care of Amyloidosis

Amyloidosis - Treatment and Management of Immunoglobulin Light Chain (AL) Amyloidosis

Amyloidosis - Treatment and Management of Transthyretin-mediated (ATTR) Amyloidosis

Amyloidosis - Treatments on the Horizon

Amyloidosis - What are the most common types of Amyloidosis?

Amyloidosis - What are the signs and symptoms?

Amyloidosis - What do we know about the genetics of Amyloidosis?

Amyloidosis - What is Amyloidosis?

Cardio Town Hall Amyloidosis: What Are the New Therapeutic Options? Lessons Learned from ACC

Congestion - How do I manage outpatient worsening of congestion in heart failure?

Congestion - New treatment options for outpatient worsening congestion in heart failure

Congestion - Oral diuretic challenges in heart congestion

Congestion - What is congestion in heart failure?

HFpEF - What are the phenotypes of HFpEF and how do they differ?

HFpEF - What do current guidelines recommend for treatment of HFpEF?

HFpEF - What is HFpEF and who does it impact?

HFpEF - What is the clinical workup for diagnosing HFpEF?

Inflammation - How does one screen for/diagnose systemic inflammation as it relates to cardiovascular disease?

Inflammation - What are current/emerging interventions for systemic inflammation in CVD, and the impact on practice?

Inflammation - What is the pathogenesis of inflammation as it relates to cardiovascular disease?

Inflammation - What is the role of systemic inflammation in ASCVD and heart failure?

SGLT2is - Current guidelines on the use of Sodium Glucose Co-transporter 2 Inhibitors (SGLT2is) in heart failure

SGLT2is - Understanding the burden of heart failure

Yes

Other (please specify)

Yes